ANAVEX LIFE SCIENCES CORP. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ANAVEX LIFE SCIENCES CORP. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q1 | 2026 | Dec 31, 2025 | ($5.68M) | Feb 9, 2026 |
| Q3 | 2025 | Jun 30, 2025 | ($13.24M) | Aug 12, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($11.20M) | May 13, 2025 |
| Q1 | 2026 | Dec 31, 2024 | ($12.11M) | Feb 9, 2026 |
| Q3 | 2025 | Jun 30, 2024 | ($12.21M) | Aug 12, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($10.55M) | May 13, 2025 |
| Q1 | 2025 | Dec 31, 2023 | ($8.62M) | Feb 12, 2025 |
| Q3 | 2024 | Jun 30, 2023 | ($11.28M) | Aug 6, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($13.11M) | May 9, 2024 |
| Q1 | 2024 | Dec 31, 2022 | ($12.97M) | Feb 7, 2024 |
| Q3 | 2023 | Jun 30, 2022 | ($12.37M) | Aug 8, 2023 |
| Q2 | 2023 | Mar 31, 2022 | ($10.44M) | May 9, 2023 |
| Q1 | 2023 | Dec 31, 2021 | ($10.88M) | Feb 7, 2023 |
| Q3 | 2021 | Jun 30, 2021 | ($10.18M) | Aug 12, 2021 |
| Q2 | 2021 | Mar 31, 2021 | ($8.16M) | May 13, 2021 |
| Q1 | 2022 | Dec 31, 2020 | ($7.86M) | Feb 9, 2022 |
| Q3 | 2021 | Jun 30, 2020 | ($6.49M) | Aug 12, 2021 |
| Q2 | 2021 | Mar 31, 2020 | ($7.24M) | May 13, 2021 |
| Q1 | 2021 | Dec 31, 2019 | ($6.59M) | Feb 16, 2021 |
| Q3 | 2020 | Jun 30, 2019 | ($6.52M) | Aug 6, 2020 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q1 | 2026 | Dec 31, 2025 | ($6.78M) | Feb 9, 2026 |
| Q3 | 2025 | Jun 30, 2025 | ($14.46M) | Aug 12, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($12.51M) | May 13, 2025 |
| Q1 | 2026 | Dec 31, 2024 | ($13.59M) | Feb 9, 2026 |
| Q3 | 2025 | Jun 30, 2024 | ($14.60M) | Aug 12, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($12.62M) | May 13, 2025 |
| Q1 | 2025 | Dec 31, 2023 | ($11.38M) | Feb 12, 2025 |
| Q3 | 2024 | Jun 30, 2023 | ($13.53M) | Aug 6, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($14.19M) | May 9, 2024 |
| Q1 | 2024 | Dec 31, 2022 | ($15.38M) | Feb 7, 2024 |
| Q3 | 2023 | Jun 30, 2022 | ($12.46M) | Aug 8, 2023 |
| Q2 | 2023 | Mar 31, 2022 | ($11.52M) | May 9, 2023 |
| Q1 | 2023 | Dec 31, 2021 | ($11.72M) | Feb 7, 2023 |
| Q3 | 2015 | Jun 30, 2015 | ($1.51M) | Aug 14, 2015 |
| Q2 | 2015 | Mar 31, 2015 | ($858.3K) | May 14, 2015 |
| Q1 | 2015 | Dec 31, 2014 | ($770.7K) | Feb 17, 2015 |
| Q3 | 2015 | Jun 30, 2014 | ($998.8K) | Aug 14, 2015 |
| Q2 | 2015 | Mar 31, 2014 | ($1.02M) | May 14, 2015 |
| Q1 | 2015 | Dec 31, 2013 | ($309.6K) | Feb 17, 2015 |
| Q3 | 2014 | Jun 30, 2013 | ($126.0K) | Aug 13, 2014 |